SCHEMBL3170298

SCHEMBL3170298

CCc1ccc(C(=O)NCCNc2cc(NCCNC(C)=O)nc(-c3ccccc3)n2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 2/20 0.46
ADORA1 P30542 2/20 0.46
ALDH1A1 P00352 7/20 0.44
CYP1A2 P05177 7/20 0.44
CYP3A4 P08684 7/20 0.44
CLK4 Q9HAZ1 6/20 0.44
HSD17B10 Q99714 3/20 0.44
ALOX15 P16050 2/20 0.44
MAPK1 P28482 2/20 0.44
ADORA3 P0DMS8 1/20 0.43
CYP2D6 P10635 4/20 0.43
TSHR P16473 3/20 0.43
KDM4E B2RXH2 2/20 0.43
MEN1 O00255 2/20 0.43
NPC1 O15118 2/20 0.43
KMT2A Q03164 2/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
CYP2C19 P33261 2/20 0.43
RAB9A P51151 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3163394 0.91 ADORA1 (0.51) ADORA2AADORA1ALDH1A1CYP1A2CYP3A4
SCHEMBL3168663 0.90 ADORA1 (0.48) ADORA2AADORA1ALDH1A1CYP1A2CYP3A4
SCHEMBL3163297 0.89 NPC1 (0.55) ALDH1A1CYP1A2MAPK1ADORA3CYP2D6
SCHEMBL3162824 0.89 ADORA1 (0.47) ADORA2AADORA1ALDH1A1CYP1A2CYP3A4
SCHEMBL3165176 0.89 POLB (0.57) ADORA2AADORA1ALDH1A1CYP1A2CYP3A4
SCHEMBL3168745 0.87 ADORA2A (0.56) ADORA2AADORA1ALDH1A1CYP1A2CYP3A4
SCHEMBL3155352 0.87 ALDH1A1 (0.47) ADORA2AADORA1ALDH1A1CYP1A2CYP3A4
SCHEMBL3156240 0.87 RAB9A (0.51) ADORA2AADORA1ALDH1A1CYP1A2CYP3A4
SCHEMBL3164826 0.86 CYP3A4 (0.49) ADORA2AADORA1ALDH1A1CYP1A2CYP3A4
SCHEMBL3258747 0.86 ADORA3 (0.57) ALDH1A1CYP1A2CYP3A4CLK4ADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 EP disclosed